Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes

Lignende værker

• Ticagrelor: An investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome
  af: Abergel, Eitan, et al.
  Udgivet: (2010)
• Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
  af: Turgeon, Ricky D., et al.
  Udgivet: (2020)
• Correlation between major adverse cardiac events and coronary plaque characteristics
  af: He, Bin, et al.
  Udgivet: (2013)
• The burden of major adverse cardiac events in patients with coronary artery disease
  af: Tsai, I-Ting, et al.
  Udgivet: (2017)
• Major adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential
  af: Røder, Michael E.
  Udgivet: (2017)